A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLNour Sabiha Naji, Theodoros Karantanos, Taha Ahmedna et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancersJiaxin Ge, Nikita Marcou, Stephanie Glavaris et al.|Nature Cancer|2025Cited by 1
CCRL2 As a Novel Target in Acute Erythroid LeukemiaNour Sabiha Naji, Theodoros Karantanos, Taha Ahmedna et al.|Blood|2024Cited by 0
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLTheodoros Karantanos, Suman Paul, Nour Sabiha Naji et al.|Research Square|2025Cited by 0
Spatial Regulation of CAR Signaling Enables Logic-Gated ActivityTushar D. Nichakawade, Kenneth W. Kinzler, Brian Mog et al.|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0